Aromatic Heterocycle-Based DPP-IV Inhibitors: Xanthines and Related Structural Types.

Author(s): Bruce G. Szczepankiewicz , Ravi Kurukulasuriya .

Journal Name: Current Topics in Medicinal Chemistry

Volume 7 , Issue 6 , 2007

Become EABM
Become Reviewer

Abstract:

Xanthines and xanthine-like DPP-IV inhibitors were first disclosed in 2002. Since then, several dozen accounts of xanthine-based DPP-IV inhibitors have been published. Only a few presentations and journal articles have appeared, with the vast majority of information coming from the patent literature. DPP-IV inhibitors related to the xanthines include purine analogues with other arrangements of the nitrogen atoms in the core structure, imidazoles, uracils, pyrimidines, pyridines, and some fused pyridines. At least one compound derived from the xanthines has advanced into clinical trials, making it likely that these molecules will play a major role in the DPP-IV inhibition arena over the next several years.

Keywords: xanthine mimetics, PYRIMIDINE-BASED DPP-IV INHIBITORS, URACIL-BASED DPP-IV INHIBITORS, Imidazole, ADME

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 7
ISSUE: 6
Year: 2007
Page: [569 - 578]
Pages: 10
DOI: 10.2174/156802607780091073
Price: $58

Article Metrics

PDF: 9